The effectiveness of oral symbiotic on Inflammation in the large intestine of neonates
Phase 1
Recruiting
- Conditions
- Preterm infant.Other preterm infants
- Registration Number
- IRCT2017080614333N79
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
Birth weight 2500 grams and less; Age of admission time 72 hours and less; Non-use of oral and topical antifungals during the last month of pregnancy.
Exclusion criteria: Prohibition of oral intake such as congenital anomalies of the jaw and mouth and digestive system; Presence of confirmed neonatal necrotizing enterocolitis; Sepsis; Simultaneous intake of antifungal or injecting drugs such as fluconazole; nystatin and amphotericin in the baby; Use of dairy products containing prebiotic or probiotic in the neonate, and coagulation or liver tests of disturbed randomized Gastroesophilia and Amphalocell prior to reconstructive surgery.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infection. Timepoint: At the beginning of the study, seven to ten days after the start of the study. Method of measurement: Stool culture.
- Secondary Outcome Measures
Name Time Method